In silico insights into the design of novel NR2B-selective NMDA receptor antagonists: QSAR modeling, ADME-toxicity predictions, molecular docking, and molecular dynamics investigations

Abstract Based on a structural family of thirty-two NR2B-selective N-Methyl-D-Aspartate receptor (NMDAR) antagonists, two phenylpiperazine derivatives labeled C37 and C39 were conceived thanks to molecular modeling techniques, as novel NMDAR inhibitors exhibiting the highest analgesic activities (of...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Mohamed El fadili, Mohammed Er-rajy, Somdutt Mujwar, Abduljelil Ajala, Rachid Bouzammit, Mohammed Kara, Hatem A. Abuelizz, Sara Er-rahmani, Menana Elhallaoui
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2024-07-01
Saila:	BMC Chemistry
Gaiak:	NMDA receptor Analgesic activity Molecular modeling Neuropathic pain MD
Sarrera elektronikoa:	https://doi.org/10.1186/s13065-024-01248-6
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!